Comparison of Curcumin Bioavailability
NCT03530436 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2019-01-10
Summary
The curcuminoids curcumin, demethoxycurcumin and bisdemethoxycurcumin can be found in the rhizome of turmeric (Curcuma longa). Curcumin is widespread used for colouring foods. Based on its natural low bioavailability and the number of its effects on human health, several approaches such as increasing its water solubility or inhibiting its metabolism were taken to improve its bioavailability. Pharmacokinetics of curcumin from various supplements using those different mechanisms have been compared to the one of native curcumin. The investigator's study here will compare the bioavailability of curcumin from eight different curcumin formulations with native curcumin and between themselves. The study will folllow a single dose (in form of curcumin formulations, normalized to 207 mg curcumin), placebo-controlled, randomized, double-blind, nine-armed crossover study design with ≥ 1-week washout periods. Plasma samples will be collected at intervals up to 24 hours after intake. Investigators will compare the pharmacokinetics between the different curcumin formulations and to native curcumin.
Conditions
- Safety After Oral Intake
- Pharmacokinetics After Oral Intake
Interventions
- DIETARY_SUPPLEMENT
-
Native turmeric extract
207 mg curcumin
- DIETARY_SUPPLEMENT
-
Native turmeric extract with 7-9% volatile turmeric oils
207 mg curcumin
- DIETARY_SUPPLEMENT
-
Turmeric extract plus mixture of phytochemicals
207 mg curcumin
- DIETARY_SUPPLEMENT
-
Cyclodextrin complex of curcuminoids
207 mg curcumin
- DIETARY_SUPPLEMENT
-
Turmeric oleoresin
207 mg curcumin
- DIETARY_SUPPLEMENT
-
Liposomal curcumin
207 mg curcumin
- DIETARY_SUPPLEMENT
-
Phytosomal curcumin
207 mg curcumin
- DIETARY_SUPPLEMENT
-
Micellar turmeric extract
207 mg curcumin
Sponsors & Collaborators
-
University of Hohenheim
lead OTHER
Principal Investigators
-
Jan Frank, Prof. Dr. · University of Hohenheim
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 35 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-06-07
- Primary Completion
- 2018-08-10
- Completion
- 2018-11-07
Countries
- Germany
Study Locations
More Related Trials
-
Bioavailability Evaluation of CurQ+ Curcumin Formulation
NCT06177483 ·Status: COMPLETED ·Phase: NA
-
A Study to Compare the Pharmacokinetic Profile of a Proprietary Curcumin Forumulation to a Comparator Curcumin Product
NCT02474953 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of Curcumin Capsules in Healthy Adult Subjects
NCT04972045 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of Curcuminoids From Turmipure Gold® in Different Food Matrices
NCT06300021 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics of Curcumin in Healthy Volunteers
NCT00181662 ·Status: COMPLETED ·Phase: NA
-
Assessing the Bioavailability of Leading Phytonutrient Products
NCT05349032 ·Status: UNKNOWN ·Phase: NA
-
Pharmacokinetics and Bioavailability of Curcumin UP 30 Capsules in Healthy Adult Subjects
NCT05334043 ·Status: UNKNOWN ·Phase: PHASE1
-
Testing the Bioavailability of Phytonutrients, Curcumin and Ursolic Acid
NCT04421716 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation
NCT07063056 ·Status: RECRUITING ·Phase: NA
-
A Nutritional Supplement Capsule Containing Curcumin, Green Tea Extract, Polygonum Cuspidatum Extract, and Soybean Extract in Healthy Participants
NCT00768118 ·Status: COMPLETED ·Phase: NA
-
Determination of Pharmacokinetics of Different Curcuminoids Preparations: Pilot Study
NCT05542394 ·Status: COMPLETED ·Phase: NA
-
Longvida Curcumin Human Pharmacokinetics Study
NCT03289507 ·Status: COMPLETED ·Phase: NA
-
Micellar Curcumin and Metabolic Syndrome Biomarkers
NCT01925547 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Effect of Turmeric in Healthy Participants
NCT05535231 ·Status: COMPLETED ·Phase: NA
-
The Effects of Nanocurcumin on Serum Oxidative Stress,Inflammation,Adiponectin and NF-kB in Blood Mononuclear Cells in Metabolic Syndrome Patients (Nuclear Factor-κB)
NCT03514667 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Increased Absorption of a Curcumin Emulsion (CurQ+) in Healthy Volunteers
NCT04103788 ·Status: COMPLETED ·Phase: NA
-
Oral Curcumin for Radiation Dermatitis
NCT01246973 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Theracurmin vs Curcumin Bioavailability Study
NCT04028739 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Effects of a Turmeric and Black Cumin Seed Formulation on Cholesterol Levels
NCT03175757 ·Status: COMPLETED ·Phase: NA
-
Curcumin and EGCG Supplementation to Improve Serum BDNF and Mood Disturbance
NCT06531863 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Effects of Curcumin on Markers of Cardiovascular Risk in Patients With CAD
NCT04458116 ·Status: WITHDRAWN ·Phase: NA
-
Effects of Curcumin Supplementation on Gut Barrier Function in Patients With Metabolic Syndrome
NCT03542240 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetic Study on Three Formulations of Curcumin With Different Carriers
NCT04382014 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Micellized Food Supplements on Health-related Quality of Life in Patients With Post-acute COVID-19 Syndrome.
NCT05150782 ·Status: UNKNOWN ·Phase: NA
-
The Effects of Oral Curcumin on Heme Oxygenase-1 (HO-1) in Healthy Male Subjects
NCT00895167 ·Status: COMPLETED ·Phase: PHASE1